ATE293968T1 - Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen - Google Patents

Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen

Info

Publication number
ATE293968T1
ATE293968T1 AT02700218T AT02700218T ATE293968T1 AT E293968 T1 ATE293968 T1 AT E293968T1 AT 02700218 T AT02700218 T AT 02700218T AT 02700218 T AT02700218 T AT 02700218T AT E293968 T1 ATE293968 T1 AT E293968T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
abdominal pain
gastrointestinal diseases
gastrointestinal
Prior art date
Application number
AT02700218T
Other languages
English (en)
Inventor
Maria Chovet
Laurent Diop
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE293968T1 publication Critical patent/ATE293968T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02700218T 2001-01-26 2002-01-25 Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen ATE293968T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01400214A EP1226820A1 (de) 2001-01-26 2001-01-26 Verwendung von bicyclische Aminosäuren zur Prophylaxe und Behandlung von Eingeweideschmerzen und gastrointestinalen Erkrankungen
PCT/EP2002/001351 WO2002058680A2 (en) 2001-01-26 2002-01-25 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders

Publications (1)

Publication Number Publication Date
ATE293968T1 true ATE293968T1 (de) 2005-05-15

Family

ID=8182608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02700218T ATE293968T1 (de) 2001-01-26 2002-01-25 Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen

Country Status (22)

Country Link
US (2) US6784208B2 (de)
EP (3) EP1226820A1 (de)
JP (2) JP2004517147A (de)
KR (1) KR20030070140A (de)
CN (1) CN1610544A (de)
AR (1) AR036009A1 (de)
AT (1) ATE293968T1 (de)
BR (1) BR0206687A (de)
CA (1) CA2435950A1 (de)
DE (1) DE60203878T2 (de)
DK (1) DK1357910T3 (de)
ES (1) ES2240686T3 (de)
IL (2) IL156667A0 (de)
MX (1) MXPA03006723A (de)
NZ (1) NZ526625A (de)
PE (1) PE20020832A1 (de)
PL (1) PL363354A1 (de)
PT (1) PT1357910E (de)
SI (1) SI1357910T1 (de)
TW (1) TWI223593B (de)
WO (1) WO2002058680A2 (de)
ZA (2) ZA200305590B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444053C (en) * 2001-04-19 2008-06-17 Warner-Lambert Company Llc Fused bicyclic or tricyclic amino acids
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
WO2006056874A1 (en) * 2004-11-25 2006-06-01 Pfizer Limited Salt form
US11467636B1 (en) * 2020-09-29 2022-10-11 Amazon Technologies, Inc. Limited blast radius storage server system
CN118370746A (zh) * 2024-04-25 2024-07-23 江苏省中医院 马尿酸在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
ATE323067T1 (de) * 1997-10-27 2006-04-15 Warner Lambert Co Zyklische aminosäuren und deren derivate als arzneimittel
EP1031350A1 (de) * 1999-02-23 2000-08-30 Warner-Lambert Company Verwendung eines Gabapentin-Analogen zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Eingeweideschmerzen
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
CA2444053C (en) * 2001-04-19 2008-06-17 Warner-Lambert Company Llc Fused bicyclic or tricyclic amino acids

Also Published As

Publication number Publication date
DE60203878T2 (de) 2006-02-16
EP1226820A1 (de) 2002-07-31
PE20020832A1 (es) 2002-10-03
BR0206687A (pt) 2004-02-03
EP1514541A1 (de) 2005-03-16
WO2002058680A3 (en) 2002-09-19
KR20030070140A (ko) 2003-08-27
ZA200305590B (en) 2004-10-18
WO2002058680A2 (en) 2002-08-01
US20020161047A1 (en) 2002-10-31
SI1357910T1 (de) 2005-08-31
PT1357910E (pt) 2005-08-31
PL363354A1 (en) 2004-11-15
JP2004517147A (ja) 2004-06-10
TWI223593B (en) 2004-11-11
CN1610544A (zh) 2005-04-27
IL156667A0 (en) 2004-01-04
EP1357910A2 (de) 2003-11-05
ES2240686T3 (es) 2005-10-16
MXPA03006723A (es) 2003-10-24
IL164012A0 (en) 2005-12-18
DK1357910T3 (da) 2005-08-08
EP1357910B1 (de) 2005-04-27
US6784208B2 (en) 2004-08-31
JP2005015492A (ja) 2005-01-20
AR036009A1 (es) 2004-08-04
CA2435950A1 (en) 2002-08-01
ZA200407412B (en) 2005-06-29
NZ526625A (en) 2004-12-24
US20040266876A1 (en) 2004-12-30
DE60203878D1 (de) 2005-06-02

Similar Documents

Publication Publication Date Title
EP1701664A4 (de) System und verfahren zur behandlung von gewebe
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
ATE413385T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE60231601D1 (de) Einrichtung und verfahren zur behandlung
ATE286028T1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE60135251D1 (de) Trokar-zugvorrichtung und verfahren
DE60327622D1 (de) Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
EP1274444A4 (de) Arzneistoffe zur behandlung psychiatrischer oder abusus-bedingter störungen
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
EP1487480A4 (de) Fusionsmoleküle und verfahren zur behandlung von immunkrankheiten
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE602004001134D1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
DE60312505D1 (de) Injektion aus ixeris sonchifolia zur behandlung von kardiozerebralen gefässerkrankungen und funduserkrankungen sowie herstellungsverfahren dafür
EP1694364A4 (de) System zur behandlung und prävention von brustkrebs
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60203878D1 (de) Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1357910

Country of ref document: EP

REN Ceased due to non-payment of the annual fee